Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M50,156Revenue (TTM) $M9,306Net Margin (%)1.1Altman Z-Score1.1
Enterprise Value $M70,421EPS (TTM) $1.6Operating Margin %5.7Piotroski F-Score5
P/E(ttm)142Beneish M-Score-1.6Pre-tax Margin (%)1.9Higher ROA y-yN
Price/Book1.810-y EBITDA Growth Rate %--Quick Ratio0.6Cash flow > EarningsY
Price/Sales4.85-y EBITDA Growth Rate %20.6Current Ratio1.3Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %-32.1ROA % (ttm)0.3Higher Current Ratio y-yY
Dividend Yield %0.5PEG3.9ROE % (ttm)0.6Less Shares Outstanding y-yN
Payout Ratio %41.0Shares Outstanding M301ROIC % (ttm)3.3Gross Margin Increase y-yN

Gurus Latest Trades with SHPG

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
SHPGKen Fisher 2016-12-31 Reduce-0.01%$163.77 - $197.7
($177.25)
$ 166.10-6%Reduce -8.96%151,274
SHPGMartin Whitman 2016-10-31 Add0.3%$168.64 - $206.56
($193.56)
$ 166.10-14%Add 46.28%61,638
SHPGJulian Robertson 2016-09-30 Reduce-2.52%$185.2 - $206.56
($195.06)
$ 166.10-15%Reduce -35.17%78,154
SHPGJohn Paulson 2016-09-30 Reduce-1.01%$185.2 - $206.56
($195.06)
$ 166.10-15%Reduce -10.14%4,667,800
SHPGLeon Cooperman 2016-09-30 Add0.91%$185.2 - $206.56
($195.06)
$ 166.10-15%Add 74.66%356,484
SHPGSteve Mandel 2016-09-30 Reduce-0.71%$185.2 - $206.56
($195.06)
$ 166.10-15%Reduce -32.99%1,694,675
SHPGThird Avenue Management 2016-09-30 Add0.18%$185.2 - $206.56
($195.06)
$ 166.10-15%Add 42.61%68,224
SHPGKen Fisher 2016-09-30 Add0.04%$185.2 - $206.56
($195.06)
$ 166.10-15%Add 276.87%166,168
SHPGTweedy Browne 2016-09-30 Reduce-0.03%$185.2 - $206.56
($195.06)
$ 166.10-15%Reduce -14.07%36,304
SHPGMario Gabelli 2016-09-30 Reduce-0.01%$185.2 - $206.56
($195.06)
$ 166.10-15%Reduce -78.86%1,242
SHPGFirst Eagle Investment 2016-09-30 Reduce$185.2 - $206.56
($195.06)
$ 166.10-15%Reduce -6.21%53,037
SHPGDavid Dreman 2016-09-30 Reduce$185.2 - $206.56
($195.06)
$ 166.10-15%Reduce -4.29%134
SHPGKeeley Asset Management Corp 2016-09-30 Reduce$185.2 - $206.56
($195.06)
$ 166.10-15%Reduce -2.26%17,322
SHPGMartin Whitman 2016-07-31 Buy 0.73%$164.64 - $195.43
($183.69)
$ 166.10-10%New holding42,138
SHPGJulian Robertson 2016-06-30 Buy 7.16%$164.64 - $192.14
($180.43)
$ 166.10-8%New holding120,554
SHPGJohn Paulson 2016-06-30 Reduce-2.44%$164.64 - $192.14
($180.43)
$ 166.10-8%Reduce -26.54%5,194,600
SHPGSteve Mandel 2016-06-30 Buy 2.15%$164.64 - $192.14
($180.43)
$ 166.10-8%New holding2,529,148
SHPGLeon Cooperman 2016-06-30 Buy 1.06%$164.64 - $192.14
($180.43)
$ 166.10-8%New holding204,100
SHPGThird Avenue Management 2016-06-30 Buy 0.39%$164.64 - $192.14
($180.43)
$ 166.10-8%New holding47,840
SHPGTweedy Browne 2016-06-30 Buy 0.22%$164.64 - $192.14
($180.43)
$ 166.10-8%New holding42,247
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

SHPG is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


SHPG: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Quarterly/Annual Reports about SHPG:

News about SHPG:

Articles On GuruFocus.com
Third Avenue Value Fund Buys 2 Stocks and Adds to 2 Positions in Q4 Dec 23 2016 
Julian Robertson Sells Delta Air Lines, Alphabet Dec 07 2016 
John Paulson's Largest 3rd Quarter Trades Dec 01 2016 
Momenta Pharmaceuticals Announces Positive Results for Humira Biosimilar Nov 30 2016 
Samuel Isaly Makes 9 New Buys in 3rd Quarter Nov 04 2016 
Martin Whitman's Top Recent Investments Oct 12 2016 
John Paulson’s Health Care Picks Plunge in Flat Year for Sector Oct 06 2016 
Whitman's Third Avenue Buys 3 Pharma Stocks in 3rd Quarter Sep 27 2016 
Mairs and Power Buys Walt Disney, Exits Baxalta Sep 27 2016 
Third Avenue Value Fund 3rd Quarter Letter Sep 14 2016 

More From Other Websites
SHIRE PLC Files SEC form 8-K, Financial Statements and Exhibits Jan 17 2017
FTSE 100 continues record run, rising for 14th day in a row Jan 13 2017
KemPharm CEO On Recent Results, Catalysts And Prospects: 'ADHD Is By Far The Larger Market... Jan 12 2017
Lawsuit accuses Shire of monopolizing market for ADHD drug Jan 12 2017
PRESS DIGEST- Financial Times - Jan 12 Jan 11 2017
[$$] Shire to Pay $350 Million to Settle Dermagraft Kickback Allegations Jan 11 2017
Pharmaceutical company agrees to ‘landmark’ settlement in Tampa federal court Jan 11 2017
Trump slams drug industry at press conference, sending biotech stocks tumbling Jan 11 2017
FTSE 100 logs 10th day of all-time highs Jan 11 2017
Shire CEO: Our innovation score is very high Jan 10 2017
Martin Whitman Invests in Homebuilder in 4th Quarter Jan 09 2017
Merrimack Pharma to Sell Cancer Drugs for $1B Jan 09 2017
SHIRE PLC Files SEC form 8-K, Financial Statements and Exhibits Jan 06 2017
For Shire PLC (ADR) (SHPG) Securing Hemophilia Market With Long Acting Version Is Crucial Jan 06 2017
Director Declaration Jan 06 2017
Here's what to expect from Mass. biotechs at this weekend's J.P. Morgan conference Jan 05 2017
Cooperman's best ideas: 14 stock picks Jan 05 2017
Billionaire James Dinan Betting On These Stocks To Recover Losses Jan 05 2017
SHIRE PLC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and... Jan 04 2017
Shire Announces Seventh Annual ... Jan 04 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)